Zidovudine and ursodeoxycholic acid conjugation: design of a new prodrug potentially able to bypass the active efflux transport systems of the central nervous system
- PMID: 22356133
- DOI: 10.1021/mp200565g
Zidovudine and ursodeoxycholic acid conjugation: design of a new prodrug potentially able to bypass the active efflux transport systems of the central nervous system
Abstract
We have synthesized a new prodrug obtained by the 5'-ester conjugation of zidovudine (AZT), an antiviral agent substrate of active efflux transport systems (AET), with ursodeoxycholic acid (UDCA), a bile acid able to permeate into the central nervous system (CNS). We have demonstrated, by HPLC analysis, that UDCA-AZT is quickly hydrolyzed in rat plasma and whole blood (half-life <10 s). The same compound was hydrolyzed with slower rates in human plasma (half-life =7.53 ± 0.44 h) and whole blood (half-life =3.71 ± 0.16 h), allowing to control the AZT release. UDCA-AZT appeared hydrolyzed also in rat brain (half-life = 7.24 ± 0.45 min) and liver homogenates (half-life = 2.70 ± 0.14 min). In the aim to study the permeation properties of the UDCA-AZT across physiological barriers, we have used an established human retinal pigment epithelium (HRPE) cell line to obtain a polarized cell monolayer showing epithelial features. The bidirectional permeation of 30 μM AZT across this monolayer was regulated by apparent permeability coefficients (P(E)) higher from the apical to basolateral compartments (P(E) = 209 ± 4 × 10⁻⁵ cm/min) than in the opposite way (P(E) = 133 ± 8 × 10⁻⁵ cm/min), in conformity with the in vivo behavior of AZT, actively effluxed from the CNS. The influx (P(E) = 39.1 ± 1.2 × 10⁻⁵ cm/min) and efflux (P(E) = 31.3 ± 3.6 × 10⁻⁵ cm/min) permeability coefficients of 30 μM UDCA-AZT were instead the same, suggesting the ability of the prodrug to avoid the AET systems and, potentially, to allow its accumulation in the CNS. The relatively low P(E) values of UDCA-AZT were associated with a partial hydrolysis during its permeation across the cell monolayer.
Similar articles
-
Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid.Drug Deliv. 2014 May;21(3):221-32. doi: 10.3109/10717544.2013.844744. Epub 2013 Oct 17. Drug Deliv. 2014. PMID: 24134683
-
Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles.Mol Pharm. 2014 May 5;11(5):1550-61. doi: 10.1021/mp400735c. Epub 2014 Apr 18. Mol Pharm. 2014. PMID: 24717116
-
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries.Antiviral Res. 2015 Nov;123:146-57. doi: 10.1016/j.antiviral.2015.09.013. Epub 2015 Sep 30. Antiviral Res. 2015. PMID: 26427553
-
[Basic studies on the utility of ursodeoxycholic acid derivatives for clinical medicine].Yakugaku Zasshi. 2000 Jan;120(1):1-15. doi: 10.1248/yakushi1947.120.1_1. Yakugaku Zasshi. 2000. PMID: 10655778 Review. Japanese.
-
Prodrugs and endogenous transporters: are they suitable tools for drug targeting into the central nervous system?Curr Pharm Des. 2011;17(32):3560-76. doi: 10.2174/138161211798194486. Curr Pharm Des. 2011. PMID: 22074427 Review.
Cited by
-
Lipids and Lipid-Processing Pathways in Drug Delivery and Therapeutics.Int J Mol Sci. 2020 May 4;21(9):3248. doi: 10.3390/ijms21093248. Int J Mol Sci. 2020. PMID: 32375338 Free PMC article. Review.
-
Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years.Molecules. 2017 Oct 16;22(10):1736. doi: 10.3390/molecules22101736. Molecules. 2017. PMID: 29035325 Free PMC article. Review.
-
Bile Acid Conjugates with Anticancer Activity: Most Recent Research.Molecules. 2020 Dec 23;26(1):25. doi: 10.3390/molecules26010025. Molecules. 2020. PMID: 33374573 Free PMC article. Review.
-
Molecular Hybridization as a Strategy for Developing Artemisinin-Derived Anticancer Candidates.Pharmaceutics. 2023 Aug 23;15(9):2185. doi: 10.3390/pharmaceutics15092185. Pharmaceutics. 2023. PMID: 37765156 Free PMC article. Review.
-
Involvement of RhoA/ROCK1 signaling pathway in hyperglycemia-induced microvascular endothelial dysfunction in diabetic retinopathy.Int J Clin Exp Pathol. 2014 Sep 15;7(10):7268-77. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25400825 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources